Lipid Systems Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Out of Business

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Out of Business

Lipid Systems General Information

Description

Developer of a pharmaceutical company designed for efficiently closing active substances in liposomes, which makes it possible to manufacture state-of-the-art forms of medicines, medical devices and dietary supplements. The company's technology can produce liposomal formulations of medicines, medical devices, food supplements and active substances efficient in closing in liposomal carriers and allowing effective transport in the body, enabling doctors to provide targeted delivery of drugs.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Krzemieniecka 48C
  • Wroclaw, 54-613
  • Poland
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Corporate Office
  • Krzemieniecka 48C
  • Wroclaw, 54-613
  • Poland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lipid Systems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 31-Aug-2024 Completed Out of Business
1. Early Stage VC Completed Startup
To view Lipid Systems’s complete valuation and funding history, request access »

Lipid Systems Patents

Lipid Systems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3937988-B1 Mri contrast agent for use in the diagnosis of changes in the endothelium of blood vessels Active 11-Mar-2019
ES-2949943-T3 Mri contrast agent for use in the diagnosis of changes in the endothelium of blood vessels Active 11-Mar-2019
EP-3937988-A1 Mri contrast agent for use in the diagnosis of early changes in the endothelium of blood vessels Active 11-Mar-2019
US-12734256-B2 Mri contrast agent for use in the diagnosis of early changes in the endothelium of blood vessels Active 11-Mar-2019
US-20220143224-A1 Mri contrast agent for use in the diagnosis of early changes in the endothelium of blood vessels Active 11-Mar-2019 A61K49/1812
To view Lipid Systems’s complete patent history, request access »

Lipid Systems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lipid Systems FAQs

  • When was Lipid Systems founded?

    Lipid Systems was founded in 2011.

  • Where is Lipid Systems headquartered?

    Lipid Systems is headquartered in Wroclaw, Poland.

  • What is the size of Lipid Systems?

    Lipid Systems has 22 total employees.

  • What industry is Lipid Systems in?

    Lipid Systems’s primary industry is Drug Delivery.

  • Is Lipid Systems a private or public company?

    Lipid Systems is a Private company.

  • What is Lipid Systems’s current revenue?

    The current revenue for Lipid Systems is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process